Skip to main content
Premium Trial:

Request an Annual Quote

Lipomics to Develop Dxs for Metabolic Diseases in Alliance With UCD

NEW YORK (GenomeWeb News) — Lipomics and the University of California, Davis will study metabolic diseases with “an emphasis on personalized medicine,” the company said today.
 
Lipomics uses bioinformatics and other analytical tools to develop profiles of lipid metabolites it can use to develop diagnostics for metabolic diseases.  
 
Under the agreement, Lipomics will retain “certain rights to develop diagnostic applications based on the data from the studies,” the company said.
 
Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.